Bethel Finance news:
Israel’s TA-25 Index retreated for a third day, declining 0.3 percent to 1,326.19 at the 4:30 p.m. close in Tel Aviv, paring the gain for the week to 0.7 percent.
Investors traded about 1.48 billion shekels ($433 million) in shares and convertible securities.
The following stocks rose or fell today. Symbols are in parentheses.
D-Pharm Ltd. (DPRM) climbed the most since Feb. 20, advancing 4 percent to 19.48 shekels. The biopharmaceutical company said its DP-b99 drug for ischemic stroke was put on “fast-track” status by the U.S. Food and Drug Administration.
Perrigo Co. (PRGO) gained for a fifth day, increasing 1.4 percent to 299.80 shekels as partner Teva Pharmaceutical Industries Ltd. (TEVA) received final over-the-counter approval to sell fexofenadine HCl, the generic equivalent of Sanofi-Aventis’ allergy drug Allegra. Teva, which already had prescription approval for the medication, added 1.1 percent to 170.40 shekels.
Separately, Teva said preliminary data from two studies showed multiple sclerosis patient improvement with use of Copaxone.
Ratio Oil Exploration 1992 LP (RATIL) decreased to the lowest since Nov. 14, falling 3.3 percent to 0.44 shekel. The oil and gas explorer is considering raising funds to finance search and development plans at assets in which it is a partner.
No comments:
Post a Comment